en

PRODUCT DETAIL

Teriflunomide Neuraxpharm 14 mg filmom obalené tablety

Code 5779E
MA number 59/0057/24-S
Product Form: tbl flm 28x1x14 mg (blis.OPA/Al/PVC - jednotk.bal.)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AA Selective immunosuppressants
L04AA31 Teriflunomide
Shelf life: 36
Container: blister OPA/Al/PVC
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 12.04.2024
Validity: 12.04.2029
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
PIL: PIL_Teriflunomide Neuraxpharm 14 mg_03.2024.pdf  
SPC: SPC_Teriflunomide Neuraxpharm 14 mg_03.2024.pdf  
Dokument: Teriflunomid_Pokyny pre zdravotníckych pracovníkov.pdf  
Dokument: Teriflunomid_Karta pre pacienta_v1_Aug2023.pdf  
Safety feature Yes
Data update: 16.04.2024
eu-flag.png sk-flag.png